Literature DB >> 12860340

Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.

Christian Fiala1, Peter Safar, Marc Bygdeman, Kristina Gemzell-Danielsson.   

Abstract

OBJECTIVES: The combination of mifepristone and misoprostol is an established method for termination of pregnancy. However, there is no general agreement about how best to evaluate the treatment outcome. STUDY
DESIGN: In 217 women with an unwanted pregnancy below 49 days of amenorrhoea, ultrasound examination and serum hCG test were performed before treatment and at follow-up.
RESULTS: Treatment was successful in 98.2%. At follow-up their hCG dropped to a mean of 3% (S.D. 3) of initial levels and the endometrium measured a mean of 10 mm (S.D. 4). Interpretation of endometrium was difficult in some cases because of inhomogeneous structure. Using hCG was reliable in 98.5% of successful abortions. For ultrasound the corresponding figure was 89.8% for the cases with a confirmed intrauterine pregnancy before treatment but only 66% if all pregnancies were included.
CONCLUSION: Measuring serum hCG before treatment and at follow-up is more effective than ultrasound to confirm a successful medically induced abortion in early pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860340     DOI: 10.1016/s0301-2115(03)00012-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  Spontaneous miscarriage in the first trimester.

Authors:  Andrew Weeks; Kristina Gemzell Danielsson
Journal:  BMJ       Date:  2006-05-27

2.  Early abortion in family medicine: clinical outcomes.

Authors:  Ian M Bennett; Margaret Baylson; Karin Kalkstein; Ginger Gillespie; Scarlett L Bellamy; Joan Fleischman
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

Review 3.  Medication to Manage Abortion and Miscarriage.

Authors:  Jessica Beaman; Christine Prifti; Eleanor Bimla Schwarz; Mindy Sobota
Journal:  J Gen Intern Med       Date:  2020-05-14       Impact factor: 5.128

Review 4.  High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.

Authors:  B Leidinger; S Bielack; G Koehler; V Vieth; W Winkelmann; G Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-24       Impact factor: 4.553

5.  Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.

Authors:  Rasha Dabash; Tara Shochet; Selma Hajri; Héla Chelli; Anne-Emmanuele Hassairi; Douha Haleb; Hayet Labassi; Ezzedine Sfar; Fatma Temimi; Leah Koenig; Beverly Winikoff
Journal:  BMC Womens Health       Date:  2016-07-30       Impact factor: 2.809

6.  Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Authors:  Mette Løkeland; Ole Erik Iversen; Anders Engeland; Ingrid Økland; Line Bjørge
Journal:  Acta Obstet Gynecol Scand       Date:  2014-05-23       Impact factor: 3.636

7.  Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.

Authors:  Ellen R Wiebe; Mackenzie Campbell; Harani Ramasamy; Michaela Kelly
Journal:  Contracept X       Date:  2020-04-11

8.  Acceptability of Home-Assessment Post Medical Abortion and Medical Abortion in a Low-Resource Setting in Rajasthan, India. Secondary Outcome Analysis of a Non-Inferiority Randomized Controlled Trial.

Authors:  Mandira Paul; Kirti Iyengar; Birgitta Essén; Kristina Gemzell-Danielsson; Sharad D Iyengar; Johan Bring; Sunita Soni; Marie Klingberg-Allvin
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

9.  Misoprostol Abortion: Ultrasonography versus Beta-hCG Testing for Verification of Effectiveness.

Authors:  Fariba Behnamfar; Mehrdad Mahdian; Fereshteh Rahimi; Mansoureh Samimi
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

10.  Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis.

Authors:  Susanne Sjöström; Helena Kopp Kallner; Emilia Simeonova; Andreas Madestam; Kristina Gemzell-Danielsson
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.